HOME > Regenerative Medicine Business

BJH LTD

Based in London, we are engaged in the regenerative medicine business. Regenerative medicine is a cutting-edge medical field that aims to fundamentally treat diseases and disorders that have been difficult to treat with conventional medicine by regenerating and repairing cells, tissues, and organs. By utilizing innovative technology and scientific advances in this field, we aim to improve patients' quality of life (QOL) and create new value in the medical field.

Future Outlook

Research and development of stem cell treatment

・ Developing treatments to regenerate damaged tissues and organs using the patient's own cells (autologous cells) or cells from another person (allogeneic cells).

・Main target diseases: arthritis, heart disease, spinal cord injury, diabetes, neurological diseases, etc.

・ We are advancing research into stem cell culture and differentiation induction techniques to improve the precision and effectiveness of treatment.

gene therapy

・ Developing technologies aimed at treating hereditary diseases and cancer through gene modification.

・ Using cutting-edge CRISPR technology, we aim to cure diseases by repairing and modifying genes.

3D bioprinting

・ Using 3D printers to artificially generate tissues and organs from cells and bioink.

・Research and development of innovative technologies to resolve the shortage of donors in transplant medicine.

Promoting clinical application

・Through clinical trials, we aim to establish safe and effective treatments.

・By partnering with medical institutions and pharmaceutical companies, we are able to quickly introduce research results into actual medical settings.

・Through our patient support program, we provide treatment opportunities to patients in need of regenerative medicine.

Stem Cell Therapy Program

Cases of improved Alzheimer's symptoms/clinical application to chronic diseases

Commercialization of gene therapy

Approaches to hemophilia treatment and cancer treatment

3D Bioprinting Achievements

Commercializing the world's first functional mini-liver printing and artificial skin printing technology

Future Outlook

・ Realization of radical treatment: Regenerative medicine goes beyond the alleviation of symptoms that conventional treatments have focused on, making it possible to treat the underlying cause of disease.

・ Solving issues in transplant medicine: Resolving issues such as donor shortages and rejection reactions, and improving patient survival rates.

・ Addressing an aging society: Regenerating tissues and organs that have deteriorated with age, improving the quality of life of the elderly.

・ Reduced medical costs: Potential to reduce medical costs for long・term disease management and treatment.

・ Expanding treatment options: Expanding the scope of current target diseases and developing treatments that can benefit more patients.

・ International expansion: Expanding London・based technology to the Middle East and Asia, particularly the Japanese market, to contribute to solving international medical issues.

・ Realization of personalized medicine: Providing custom・made treatments based on each patient's genetic information and health condition.

BJH LTD shapes the future of medical technology,
We aim to create a society where patients around the world can have hope.